[Federal Register: September 17, 1998 (Volume 63, Number 180)]
[Notices]               
[Page 49698]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17se98-57]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Science Board to the Food and Drug Administration; Notice of 
Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Science Board to the Food and Drug 
Administration.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on October 21, 1998, 9 a.m. 
to 4 p.m.
    Location: Washington Plaza Hotel, Washington Room, 10 Thomas 
Circle, NW., Washington, DC.
    Contact Person: Susan K. Meadows, Office of Science (HF-32), Food 
and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-
827-4591, or FDA Advisory Committee Information Line, 1-800-741-8138 
(301-443-0572 in the Washington, DC area), code 12603. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: Information will be presented to the board regarding broad 
scientific and technical issues including: (1) A proposal for review of 
research conducted at the Center for Food Safety and Applied Nutrition, 
(2) the process for external peer review of research programs, (3) 
operational models for FDA science and research management and 
coordination, and (4) scientific issues of interest to FDA 
stakeholders.
    Procedure: On October 21, 1998, from 10 a.m. to 4 p.m., the meeting 
is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
October 1, 1998. Oral presentations from the public will be scheduled 
between approximately 2:30 p.m. and 3:30 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person by October 1, 1998, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Closed Committee Deliberations: On October 21, 1998, from 9 a.m. to 
10 a.m., the meeting will be closed to permit discussion where 
disclosure would constitute a clearly unwarranted invasion of personal 
privacy (5 U.S.C. 552b(c)(6)). The board will discuss nominations for 
the FDA Awards for Scientific Achievement. Such discussion in a public 
meeting would disclose information of a personal nature and would 
constitute an invasion of personal privacy.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: September 10, 1998.
William B. Schultz,
Acting Commissioner of Food and Drugs.
[FR Doc. 98-24865 Filed 9-16-98; 8:45 am]
BILLING CODE 4160-01-F